Mohamed Mohamed Abdulkadir, Ding Shuai, Ali Shah Sayed Zulfiqar, Li Rui, Dirie Najib Isse, Cheng Cai, Wei Xiang
Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Cardiovasc Med. 2021 Aug 23;8:724178. doi: 10.3389/fcvm.2021.724178. eCollection 2021.
Postoperative pulmonary complications remain a leading cause of increased morbidity, mortality, longer hospital stays, and increased costs after cardiac surgery; therefore, our study aims to analyze whether minimally invasive valve surgery (MIVS) for both aortic and mitral valves can improve pulmonary function and reduce the incidence of postoperative pulmonary complications when compared with the full median sternotomy (FS) approach. A comprehensive systematic literature research was performed for studies comparing MIVS and FS up to February 2021. Randomized controlled trials (RCTs) and propensity score-matching (PSM) studies comparing early respiratory function and pulmonary complications after MIVS and FS were extracted and analyzed. Secondary outcomes included intra- and postoperative outcomes. A total of 10,194 patients from 30 studies (6 RCTs and 24 PSM studies) were analyzed. Early mortality differed significantly between the groups (MIVS 1.2 vs. FS 1.9%; = 0.005). Compared with FS, MIVS significantly lowered the incidence of postoperative pulmonary complications (odds ratio 0.79, 95% confidence interval [0.67, 0.93]; = 0.004) and improved early postoperative respiratory function status (mean difference -24.83 [-29.90, -19.76]; < 0.00001). Blood transfusion amount was significantly lower after MIVS ( < 0.02), whereas cardiopulmonary bypass time and aortic cross-clamp time were significantly longer after MIVS ( < 0.00001). Our study showed that minimally invasive valve surgery decreases the incidence of postoperative pulmonary complications and improves postoperative respiratory function status.
术后肺部并发症仍然是心脏手术后发病率增加、死亡率上升、住院时间延长和成本增加的主要原因;因此,我们的研究旨在分析与完全正中胸骨切开术(FS)相比,主动脉瓣和二尖瓣的微创瓣膜手术(MIVS)是否能改善肺功能并降低术后肺部并发症的发生率。对截至2021年2月比较MIVS和FS的研究进行了全面的系统文献检索。提取并分析了比较MIVS和FS术后早期呼吸功能和肺部并发症的随机对照试验(RCT)和倾向得分匹配(PSM)研究。次要结局包括术中和术后结局。共分析了来自30项研究(6项RCT和24项PSM研究)的10194例患者。两组之间的早期死亡率差异显著(MIVS为1.2%,FS为1.9%;P = 0.005)。与FS相比,MIVS显著降低了术后肺部并发症的发生率(优势比0.79,95%置信区间[0.67,0.93];P = 0.004),并改善了术后早期呼吸功能状态(平均差异-24.83[-29.90,-19.76];P < 0.00001)。MIVS术后输血总量显著更低(P < 0.02),而MIVS术后体外循环时间和主动脉阻断时间显著更长(P < 0.00001)。我们的研究表明,微创瓣膜手术可降低术后肺部并发症的发生率并改善术后呼吸功能状态。